Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers

Background Smoking is an important cause of morbidity and mortality worldwide. It iswidely accepted as a major risk factor for metabolic and cardiovasculardisease. Smoking reduces insulin sensitivity or induces insulin resistanceand enhances cardiovascular risk factors such as elevated plasmatriglyc...
Ausführliche Beschreibung

Gespeichert in:

Autor*in:	Cena, Hellas [verfasserIn] Tesone, Antonella Niniano, Rosanna Cerveri, Isa Roggi, Carla Turconi, Giovanna

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2013

Schlagwörter:	Metabolic syndrome Smoking habit Insulin resistance Overweight Waist circumference

Anmerkung:	© Cena et al.; licensee BioMed Central Ltd. 2013

Übergeordnetes Werk:	Enthalten in: Diabetology & metabolic syndrome - London : BioMed Central, 2009, 5(2013), 1 vom: 30. Mai
Übergeordnetes Werk:	volume:5 ; year:2013 ; number:1 ; day:30 ; month:05

Links:	Volltext

DOI / URN:	10.1186/1758-5996-5-28

Katalog-ID:	SPR030240395

Internformat


LEADER	01000caa a22002652 4500
001	SPR030240395
003	DE-627
005	20230519143130.0
007	cr uuu---uuuuu
008	201007s2013 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1186/1758-5996-5-28 \|2 doi
035			\|a (DE-627)SPR030240395
035			\|a (SPR)1758-5996-5-28-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
100	1		\|a Cena, Hellas \|e verfasserin \|4 aut
245	1	0	\|a Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers
264		1	\|c 2013
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Cena et al.; licensee BioMed Central Ltd. 2013
520			\|a Background Smoking is an important cause of morbidity and mortality worldwide. It iswidely accepted as a major risk factor for metabolic and cardiovasculardisease. Smoking reduces insulin sensitivity or induces insulin resistanceand enhances cardiovascular risk factors such as elevated plasmatriglycerides, decreases high-density lipoprotein cholesterol and causeshyperglycemia. Several studies show that smoking is associated withmetabolic abnormalities and increases the risk of Metabolic Syndrome. Theaim of this study was to estimate the prevalence of the metabolic syndromein a group of light and heavy smokers, wishing to give up smoking. Methods In this cross-sectional study all the enrolled subjects voluntary joined thesmoking cessation program held by the Respiratory Pathophysiology Unit ofSan Matteo Hospital, Pavia, Northern Italy. All the subjects enrolled were former smokers from at least 10 years and hadno cancer or psychiatric disorders, nor history of diabetes or CVD orcoronary artery disease and were not on any medication. Results The subjects smoke 32.3 ± 16.5 mean Pack Years. Theprevalence of the metabolic syndrome is 52.1%: 57.3% and 44.9% for males andfemales respectively. Analysing the smoking habit influence on the IDFcriteria for the metabolic syndrome diagnosis we found that all thevariables show an increasing trend from light to heavy smokers, except forHDL cholesterol. A statistical significant correlation among Pack Years andwaist circumference (R = 0.48, p < 0.0001),Systolic Blood Pressure (R = 0.18, p < 0.05),fasting plasma glucose (R = 0.19, p < 0.005) andHDL cholesterol (R = −0.26, p = 0.0005) hasbeen observed. Conclusions Currently smoking subjects are at high risk of developing the metabolicsyndrome. Therapeutic lifestyle changes, including smoking cessation are a desirablePublic health goal and should successfully be implemented in clinicalpractice at any age.
650		4	\|a Metabolic syndrome \|7 (dpeaa)DE-He213
650		4	\|a Smoking habit \|7 (dpeaa)DE-He213
650		4	\|a Insulin resistance \|7 (dpeaa)DE-He213
650		4	\|a Overweight \|7 (dpeaa)DE-He213
650		4	\|a Waist circumference \|7 (dpeaa)DE-He213
700	1		\|a Tesone, Antonella \|4 aut
700	1		\|a Niniano, Rosanna \|4 aut
700	1		\|a Cerveri, Isa \|4 aut
700	1		\|a Roggi, Carla \|4 aut
700	1		\|a Turconi, Giovanna \|4 aut
773	0	8	\|i Enthalten in \|t Diabetology & metabolic syndrome \|d London : BioMed Central, 2009 \|g 5(2013), 1 vom: 30. Mai \|w (DE-627)610606689 \|w (DE-600)2518786-7 \|x 1758-5996 \|7 nnns
773	1	8	\|g volume:5 \|g year:2013 \|g number:1 \|g day:30 \|g month:05
856	4	0	\|u https://dx.doi.org/10.1186/1758-5996-5-28 \|z kostenfrei \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_11
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_95
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_151
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_206
912			\|a GBV_ILN_213
912			\|a GBV_ILN_230
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_602
912			\|a GBV_ILN_2003
912			\|a GBV_ILN_2005
912			\|a GBV_ILN_2009
912			\|a GBV_ILN_2011
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_2055
912			\|a GBV_ILN_2111
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4367
912			\|a GBV_ILN_4700
951			\|a AR
952			\|d 5 \|j 2013 \|e 1 \|b 30 \|c 05

Indexfelder

author_variant	h c hc a t at r n rn i c ic c r cr g t gt
matchkey_str	article:17585996:2013----::rvlneaefeaoisnrmiaruol
hierarchy_sort_str	2013
publishDate	2013
allfields	10.1186/1758-5996-5-28 doi (DE-627)SPR030240395 (SPR)1758-5996-5-28-e DE-627 ger DE-627 rakwb eng Cena, Hellas verfasserin aut Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Cena et al.; licensee BioMed Central Ltd. 2013 Background Smoking is an important cause of morbidity and mortality worldwide. It iswidely accepted as a major risk factor for metabolic and cardiovasculardisease. Smoking reduces insulin sensitivity or induces insulin resistanceand enhances cardiovascular risk factors such as elevated plasmatriglycerides, decreases high-density lipoprotein cholesterol and causeshyperglycemia. Several studies show that smoking is associated withmetabolic abnormalities and increases the risk of Metabolic Syndrome. Theaim of this study was to estimate the prevalence of the metabolic syndromein a group of light and heavy smokers, wishing to give up smoking. Methods In this cross-sectional study all the enrolled subjects voluntary joined thesmoking cessation program held by the Respiratory Pathophysiology Unit ofSan Matteo Hospital, Pavia, Northern Italy. All the subjects enrolled were former smokers from at least 10 years and hadno cancer or psychiatric disorders, nor history of diabetes or CVD orcoronary artery disease and were not on any medication. Results The subjects smoke 32.3 ± 16.5 mean Pack Years. Theprevalence of the metabolic syndrome is 52.1%: 57.3% and 44.9% for males andfemales respectively. Analysing the smoking habit influence on the IDFcriteria for the metabolic syndrome diagnosis we found that all thevariables show an increasing trend from light to heavy smokers, except forHDL cholesterol. A statistical significant correlation among Pack Years andwaist circumference (R = 0.48, p < 0.0001),Systolic Blood Pressure (R = 0.18, p < 0.05),fasting plasma glucose (R = 0.19, p < 0.005) andHDL cholesterol (R = −0.26, p = 0.0005) hasbeen observed. Conclusions Currently smoking subjects are at high risk of developing the metabolicsyndrome. Therapeutic lifestyle changes, including smoking cessation are a desirablePublic health goal and should successfully be implemented in clinicalpractice at any age. Metabolic syndrome (dpeaa)DE-He213 Smoking habit (dpeaa)DE-He213 Insulin resistance (dpeaa)DE-He213 Overweight (dpeaa)DE-He213 Waist circumference (dpeaa)DE-He213 Tesone, Antonella aut Niniano, Rosanna aut Cerveri, Isa aut Roggi, Carla aut Turconi, Giovanna aut Enthalten in Diabetology & metabolic syndrome London : BioMed Central, 2009 5(2013), 1 vom: 30. Mai (DE-627)610606689 (DE-600)2518786-7 1758-5996 nnns volume:5 year:2013 number:1 day:30 month:05 https://dx.doi.org/10.1186/1758-5996-5-28 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 5 2013 1 30 05
spelling	10.1186/1758-5996-5-28 doi (DE-627)SPR030240395 (SPR)1758-5996-5-28-e DE-627 ger DE-627 rakwb eng Cena, Hellas verfasserin aut Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Cena et al.; licensee BioMed Central Ltd. 2013 Background Smoking is an important cause of morbidity and mortality worldwide. It iswidely accepted as a major risk factor for metabolic and cardiovasculardisease. Smoking reduces insulin sensitivity or induces insulin resistanceand enhances cardiovascular risk factors such as elevated plasmatriglycerides, decreases high-density lipoprotein cholesterol and causeshyperglycemia. Several studies show that smoking is associated withmetabolic abnormalities and increases the risk of Metabolic Syndrome. Theaim of this study was to estimate the prevalence of the metabolic syndromein a group of light and heavy smokers, wishing to give up smoking. Methods In this cross-sectional study all the enrolled subjects voluntary joined thesmoking cessation program held by the Respiratory Pathophysiology Unit ofSan Matteo Hospital, Pavia, Northern Italy. All the subjects enrolled were former smokers from at least 10 years and hadno cancer or psychiatric disorders, nor history of diabetes or CVD orcoronary artery disease and were not on any medication. Results The subjects smoke 32.3 ± 16.5 mean Pack Years. Theprevalence of the metabolic syndrome is 52.1%: 57.3% and 44.9% for males andfemales respectively. Analysing the smoking habit influence on the IDFcriteria for the metabolic syndrome diagnosis we found that all thevariables show an increasing trend from light to heavy smokers, except forHDL cholesterol. A statistical significant correlation among Pack Years andwaist circumference (R = 0.48, p < 0.0001),Systolic Blood Pressure (R = 0.18, p < 0.05),fasting plasma glucose (R = 0.19, p < 0.005) andHDL cholesterol (R = −0.26, p = 0.0005) hasbeen observed. Conclusions Currently smoking subjects are at high risk of developing the metabolicsyndrome. Therapeutic lifestyle changes, including smoking cessation are a desirablePublic health goal and should successfully be implemented in clinicalpractice at any age. Metabolic syndrome (dpeaa)DE-He213 Smoking habit (dpeaa)DE-He213 Insulin resistance (dpeaa)DE-He213 Overweight (dpeaa)DE-He213 Waist circumference (dpeaa)DE-He213 Tesone, Antonella aut Niniano, Rosanna aut Cerveri, Isa aut Roggi, Carla aut Turconi, Giovanna aut Enthalten in Diabetology & metabolic syndrome London : BioMed Central, 2009 5(2013), 1 vom: 30. Mai (DE-627)610606689 (DE-600)2518786-7 1758-5996 nnns volume:5 year:2013 number:1 day:30 month:05 https://dx.doi.org/10.1186/1758-5996-5-28 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 5 2013 1 30 05
allfields_unstemmed	10.1186/1758-5996-5-28 doi (DE-627)SPR030240395 (SPR)1758-5996-5-28-e DE-627 ger DE-627 rakwb eng Cena, Hellas verfasserin aut Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Cena et al.; licensee BioMed Central Ltd. 2013 Background Smoking is an important cause of morbidity and mortality worldwide. It iswidely accepted as a major risk factor for metabolic and cardiovasculardisease. Smoking reduces insulin sensitivity or induces insulin resistanceand enhances cardiovascular risk factors such as elevated plasmatriglycerides, decreases high-density lipoprotein cholesterol and causeshyperglycemia. Several studies show that smoking is associated withmetabolic abnormalities and increases the risk of Metabolic Syndrome. Theaim of this study was to estimate the prevalence of the metabolic syndromein a group of light and heavy smokers, wishing to give up smoking. Methods In this cross-sectional study all the enrolled subjects voluntary joined thesmoking cessation program held by the Respiratory Pathophysiology Unit ofSan Matteo Hospital, Pavia, Northern Italy. All the subjects enrolled were former smokers from at least 10 years and hadno cancer or psychiatric disorders, nor history of diabetes or CVD orcoronary artery disease and were not on any medication. Results The subjects smoke 32.3 ± 16.5 mean Pack Years. Theprevalence of the metabolic syndrome is 52.1%: 57.3% and 44.9% for males andfemales respectively. Analysing the smoking habit influence on the IDFcriteria for the metabolic syndrome diagnosis we found that all thevariables show an increasing trend from light to heavy smokers, except forHDL cholesterol. A statistical significant correlation among Pack Years andwaist circumference (R = 0.48, p < 0.0001),Systolic Blood Pressure (R = 0.18, p < 0.05),fasting plasma glucose (R = 0.19, p < 0.005) andHDL cholesterol (R = −0.26, p = 0.0005) hasbeen observed. Conclusions Currently smoking subjects are at high risk of developing the metabolicsyndrome. Therapeutic lifestyle changes, including smoking cessation are a desirablePublic health goal and should successfully be implemented in clinicalpractice at any age. Metabolic syndrome (dpeaa)DE-He213 Smoking habit (dpeaa)DE-He213 Insulin resistance (dpeaa)DE-He213 Overweight (dpeaa)DE-He213 Waist circumference (dpeaa)DE-He213 Tesone, Antonella aut Niniano, Rosanna aut Cerveri, Isa aut Roggi, Carla aut Turconi, Giovanna aut Enthalten in Diabetology & metabolic syndrome London : BioMed Central, 2009 5(2013), 1 vom: 30. Mai (DE-627)610606689 (DE-600)2518786-7 1758-5996 nnns volume:5 year:2013 number:1 day:30 month:05 https://dx.doi.org/10.1186/1758-5996-5-28 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 5 2013 1 30 05
allfieldsGer	10.1186/1758-5996-5-28 doi (DE-627)SPR030240395 (SPR)1758-5996-5-28-e DE-627 ger DE-627 rakwb eng Cena, Hellas verfasserin aut Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Cena et al.; licensee BioMed Central Ltd. 2013 Background Smoking is an important cause of morbidity and mortality worldwide. It iswidely accepted as a major risk factor for metabolic and cardiovasculardisease. Smoking reduces insulin sensitivity or induces insulin resistanceand enhances cardiovascular risk factors such as elevated plasmatriglycerides, decreases high-density lipoprotein cholesterol and causeshyperglycemia. Several studies show that smoking is associated withmetabolic abnormalities and increases the risk of Metabolic Syndrome. Theaim of this study was to estimate the prevalence of the metabolic syndromein a group of light and heavy smokers, wishing to give up smoking. Methods In this cross-sectional study all the enrolled subjects voluntary joined thesmoking cessation program held by the Respiratory Pathophysiology Unit ofSan Matteo Hospital, Pavia, Northern Italy. All the subjects enrolled were former smokers from at least 10 years and hadno cancer or psychiatric disorders, nor history of diabetes or CVD orcoronary artery disease and were not on any medication. Results The subjects smoke 32.3 ± 16.5 mean Pack Years. Theprevalence of the metabolic syndrome is 52.1%: 57.3% and 44.9% for males andfemales respectively. Analysing the smoking habit influence on the IDFcriteria for the metabolic syndrome diagnosis we found that all thevariables show an increasing trend from light to heavy smokers, except forHDL cholesterol. A statistical significant correlation among Pack Years andwaist circumference (R = 0.48, p < 0.0001),Systolic Blood Pressure (R = 0.18, p < 0.05),fasting plasma glucose (R = 0.19, p < 0.005) andHDL cholesterol (R = −0.26, p = 0.0005) hasbeen observed. Conclusions Currently smoking subjects are at high risk of developing the metabolicsyndrome. Therapeutic lifestyle changes, including smoking cessation are a desirablePublic health goal and should successfully be implemented in clinicalpractice at any age. Metabolic syndrome (dpeaa)DE-He213 Smoking habit (dpeaa)DE-He213 Insulin resistance (dpeaa)DE-He213 Overweight (dpeaa)DE-He213 Waist circumference (dpeaa)DE-He213 Tesone, Antonella aut Niniano, Rosanna aut Cerveri, Isa aut Roggi, Carla aut Turconi, Giovanna aut Enthalten in Diabetology & metabolic syndrome London : BioMed Central, 2009 5(2013), 1 vom: 30. Mai (DE-627)610606689 (DE-600)2518786-7 1758-5996 nnns volume:5 year:2013 number:1 day:30 month:05 https://dx.doi.org/10.1186/1758-5996-5-28 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 5 2013 1 30 05
allfieldsSound	10.1186/1758-5996-5-28 doi (DE-627)SPR030240395 (SPR)1758-5996-5-28-e DE-627 ger DE-627 rakwb eng Cena, Hellas verfasserin aut Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Cena et al.; licensee BioMed Central Ltd. 2013 Background Smoking is an important cause of morbidity and mortality worldwide. It iswidely accepted as a major risk factor for metabolic and cardiovasculardisease. Smoking reduces insulin sensitivity or induces insulin resistanceand enhances cardiovascular risk factors such as elevated plasmatriglycerides, decreases high-density lipoprotein cholesterol and causeshyperglycemia. Several studies show that smoking is associated withmetabolic abnormalities and increases the risk of Metabolic Syndrome. Theaim of this study was to estimate the prevalence of the metabolic syndromein a group of light and heavy smokers, wishing to give up smoking. Methods In this cross-sectional study all the enrolled subjects voluntary joined thesmoking cessation program held by the Respiratory Pathophysiology Unit ofSan Matteo Hospital, Pavia, Northern Italy. All the subjects enrolled were former smokers from at least 10 years and hadno cancer or psychiatric disorders, nor history of diabetes or CVD orcoronary artery disease and were not on any medication. Results The subjects smoke 32.3 ± 16.5 mean Pack Years. Theprevalence of the metabolic syndrome is 52.1%: 57.3% and 44.9% for males andfemales respectively. Analysing the smoking habit influence on the IDFcriteria for the metabolic syndrome diagnosis we found that all thevariables show an increasing trend from light to heavy smokers, except forHDL cholesterol. A statistical significant correlation among Pack Years andwaist circumference (R = 0.48, p < 0.0001),Systolic Blood Pressure (R = 0.18, p < 0.05),fasting plasma glucose (R = 0.19, p < 0.005) andHDL cholesterol (R = −0.26, p = 0.0005) hasbeen observed. Conclusions Currently smoking subjects are at high risk of developing the metabolicsyndrome. Therapeutic lifestyle changes, including smoking cessation are a desirablePublic health goal and should successfully be implemented in clinicalpractice at any age. Metabolic syndrome (dpeaa)DE-He213 Smoking habit (dpeaa)DE-He213 Insulin resistance (dpeaa)DE-He213 Overweight (dpeaa)DE-He213 Waist circumference (dpeaa)DE-He213 Tesone, Antonella aut Niniano, Rosanna aut Cerveri, Isa aut Roggi, Carla aut Turconi, Giovanna aut Enthalten in Diabetology & metabolic syndrome London : BioMed Central, 2009 5(2013), 1 vom: 30. Mai (DE-627)610606689 (DE-600)2518786-7 1758-5996 nnns volume:5 year:2013 number:1 day:30 month:05 https://dx.doi.org/10.1186/1758-5996-5-28 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 5 2013 1 30 05
language	English
source	Enthalten in Diabetology & metabolic syndrome 5(2013), 1 vom: 30. Mai volume:5 year:2013 number:1 day:30 month:05
sourceStr	Enthalten in Diabetology & metabolic syndrome 5(2013), 1 vom: 30. Mai volume:5 year:2013 number:1 day:30 month:05
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Metabolic syndrome Smoking habit Insulin resistance Overweight Waist circumference
isfreeaccess_bool	true
container_title	Diabetology & metabolic syndrome
authorswithroles_txt_mv	Cena, Hellas @@aut@@ Tesone, Antonella @@aut@@ Niniano, Rosanna @@aut@@ Cerveri, Isa @@aut@@ Roggi, Carla @@aut@@ Turconi, Giovanna @@aut@@
publishDateDaySort_date	2013-05-30T00:00:00Z
hierarchy_top_id	610606689
id	SPR030240395
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR030240395</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519143130.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2013 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1186/1758-5996-5-28</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR030240395</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)1758-5996-5-28-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Cena, Hellas</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Cena et al.; licensee BioMed Central Ltd. 2013</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background Smoking is an important cause of morbidity and mortality worldwide. It iswidely accepted as a major risk factor for metabolic and cardiovasculardisease. Smoking reduces insulin sensitivity or induces insulin resistanceand enhances cardiovascular risk factors such as elevated plasmatriglycerides, decreases high-density lipoprotein cholesterol and causeshyperglycemia. Several studies show that smoking is associated withmetabolic abnormalities and increases the risk of Metabolic Syndrome. Theaim of this study was to estimate the prevalence of the metabolic syndromein a group of light and heavy smokers, wishing to give up smoking. Methods In this cross-sectional study all the enrolled subjects voluntary joined thesmoking cessation program held by the Respiratory Pathophysiology Unit ofSan Matteo Hospital, Pavia, Northern Italy. All the subjects enrolled were former smokers from at least 10 years and hadno cancer or psychiatric disorders, nor history of diabetes or CVD orcoronary artery disease and were not on any medication. Results The subjects smoke 32.3 ± 16.5 mean Pack Years. Theprevalence of the metabolic syndrome is 52.1%: 57.3% and 44.9% for males andfemales respectively. Analysing the smoking habit influence on the IDFcriteria for the metabolic syndrome diagnosis we found that all thevariables show an increasing trend from light to heavy smokers, except forHDL cholesterol. A statistical significant correlation among Pack Years andwaist circumference (R = 0.48, p < 0.0001),Systolic Blood Pressure (R = 0.18, p < 0.05),fasting plasma glucose (R = 0.19, p < 0.005) andHDL cholesterol (R = −0.26, p = 0.0005) hasbeen observed. Conclusions Currently smoking subjects are at high risk of developing the metabolicsyndrome. Therapeutic lifestyle changes, including smoking cessation are a desirablePublic health goal and should successfully be implemented in clinicalpractice at any age.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Metabolic syndrome</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Smoking habit</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Insulin resistance</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Overweight</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Waist circumference</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tesone, Antonella</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Niniano, Rosanna</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cerveri, Isa</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Roggi, Carla</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Turconi, Giovanna</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Diabetology & metabolic syndrome</subfield><subfield code="d">London : BioMed Central, 2009</subfield><subfield code="g">5(2013), 1 vom: 30. Mai</subfield><subfield code="w">(DE-627)610606689</subfield><subfield code="w">(DE-600)2518786-7</subfield><subfield code="x">1758-5996</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:5</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:1</subfield><subfield code="g">day:30</subfield><subfield code="g">month:05</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1186/1758-5996-5-28</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">5</subfield><subfield code="j">2013</subfield><subfield code="e">1</subfield><subfield code="b">30</subfield><subfield code="c">05</subfield></datafield></record></collection>
author	Cena, Hellas
spellingShingle	Cena, Hellas misc Metabolic syndrome misc Smoking habit misc Insulin resistance misc Overweight misc Waist circumference Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers
authorStr	Cena, Hellas
ppnlink_with_tag_str_mv	@@773@@(DE-627)610606689
format	electronic Article
delete_txt_mv	keep
author_role	aut aut aut aut aut aut
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	1758-5996
topic_title	Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers Metabolic syndrome (dpeaa)DE-He213 Smoking habit (dpeaa)DE-He213 Insulin resistance (dpeaa)DE-He213 Overweight (dpeaa)DE-He213 Waist circumference (dpeaa)DE-He213
topic	misc Metabolic syndrome misc Smoking habit misc Insulin resistance misc Overweight misc Waist circumference
topic_unstemmed	misc Metabolic syndrome misc Smoking habit misc Insulin resistance misc Overweight misc Waist circumference
topic_browse	misc Metabolic syndrome misc Smoking habit misc Insulin resistance misc Overweight misc Waist circumference
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Diabetology & metabolic syndrome
hierarchy_parent_id	610606689
hierarchy_top_title	Diabetology & metabolic syndrome
isfreeaccess_txt	true
familylinks_str_mv	(DE-627)610606689 (DE-600)2518786-7
title	Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers
ctrlnum	(DE-627)SPR030240395 (SPR)1758-5996-5-28-e
title_full	Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers
author_sort	Cena, Hellas
journal	Diabetology & metabolic syndrome
journalStr	Diabetology & metabolic syndrome
lang_code	eng
isOA_bool	true
recordtype	marc
publishDateSort	2013
contenttype_str_mv	txt
author_browse	Cena, Hellas Tesone, Antonella Niniano, Rosanna Cerveri, Isa Roggi, Carla Turconi, Giovanna
container_volume	5
format_se	Elektronische Aufsätze
author-letter	Cena, Hellas
doi_str_mv	10.1186/1758-5996-5-28
title_sort	prevalence rate of metabolic syndrome in a group of light and heavy smokers
title_auth	Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers
abstract	Background Smoking is an important cause of morbidity and mortality worldwide. It iswidely accepted as a major risk factor for metabolic and cardiovasculardisease. Smoking reduces insulin sensitivity or induces insulin resistanceand enhances cardiovascular risk factors such as elevated plasmatriglycerides, decreases high-density lipoprotein cholesterol and causeshyperglycemia. Several studies show that smoking is associated withmetabolic abnormalities and increases the risk of Metabolic Syndrome. Theaim of this study was to estimate the prevalence of the metabolic syndromein a group of light and heavy smokers, wishing to give up smoking. Methods In this cross-sectional study all the enrolled subjects voluntary joined thesmoking cessation program held by the Respiratory Pathophysiology Unit ofSan Matteo Hospital, Pavia, Northern Italy. All the subjects enrolled were former smokers from at least 10 years and hadno cancer or psychiatric disorders, nor history of diabetes or CVD orcoronary artery disease and were not on any medication. Results The subjects smoke 32.3 ± 16.5 mean Pack Years. Theprevalence of the metabolic syndrome is 52.1%: 57.3% and 44.9% for males andfemales respectively. Analysing the smoking habit influence on the IDFcriteria for the metabolic syndrome diagnosis we found that all thevariables show an increasing trend from light to heavy smokers, except forHDL cholesterol. A statistical significant correlation among Pack Years andwaist circumference (R = 0.48, p < 0.0001),Systolic Blood Pressure (R = 0.18, p < 0.05),fasting plasma glucose (R = 0.19, p < 0.005) andHDL cholesterol (R = −0.26, p = 0.0005) hasbeen observed. Conclusions Currently smoking subjects are at high risk of developing the metabolicsyndrome. Therapeutic lifestyle changes, including smoking cessation are a desirablePublic health goal and should successfully be implemented in clinicalpractice at any age. © Cena et al.; licensee BioMed Central Ltd. 2013
abstractGer	Background Smoking is an important cause of morbidity and mortality worldwide. It iswidely accepted as a major risk factor for metabolic and cardiovasculardisease. Smoking reduces insulin sensitivity or induces insulin resistanceand enhances cardiovascular risk factors such as elevated plasmatriglycerides, decreases high-density lipoprotein cholesterol and causeshyperglycemia. Several studies show that smoking is associated withmetabolic abnormalities and increases the risk of Metabolic Syndrome. Theaim of this study was to estimate the prevalence of the metabolic syndromein a group of light and heavy smokers, wishing to give up smoking. Methods In this cross-sectional study all the enrolled subjects voluntary joined thesmoking cessation program held by the Respiratory Pathophysiology Unit ofSan Matteo Hospital, Pavia, Northern Italy. All the subjects enrolled were former smokers from at least 10 years and hadno cancer or psychiatric disorders, nor history of diabetes or CVD orcoronary artery disease and were not on any medication. Results The subjects smoke 32.3 ± 16.5 mean Pack Years. Theprevalence of the metabolic syndrome is 52.1%: 57.3% and 44.9% for males andfemales respectively. Analysing the smoking habit influence on the IDFcriteria for the metabolic syndrome diagnosis we found that all thevariables show an increasing trend from light to heavy smokers, except forHDL cholesterol. A statistical significant correlation among Pack Years andwaist circumference (R = 0.48, p < 0.0001),Systolic Blood Pressure (R = 0.18, p < 0.05),fasting plasma glucose (R = 0.19, p < 0.005) andHDL cholesterol (R = −0.26, p = 0.0005) hasbeen observed. Conclusions Currently smoking subjects are at high risk of developing the metabolicsyndrome. Therapeutic lifestyle changes, including smoking cessation are a desirablePublic health goal and should successfully be implemented in clinicalpractice at any age. © Cena et al.; licensee BioMed Central Ltd. 2013
abstract_unstemmed	Background Smoking is an important cause of morbidity and mortality worldwide. It iswidely accepted as a major risk factor for metabolic and cardiovasculardisease. Smoking reduces insulin sensitivity or induces insulin resistanceand enhances cardiovascular risk factors such as elevated plasmatriglycerides, decreases high-density lipoprotein cholesterol and causeshyperglycemia. Several studies show that smoking is associated withmetabolic abnormalities and increases the risk of Metabolic Syndrome. Theaim of this study was to estimate the prevalence of the metabolic syndromein a group of light and heavy smokers, wishing to give up smoking. Methods In this cross-sectional study all the enrolled subjects voluntary joined thesmoking cessation program held by the Respiratory Pathophysiology Unit ofSan Matteo Hospital, Pavia, Northern Italy. All the subjects enrolled were former smokers from at least 10 years and hadno cancer or psychiatric disorders, nor history of diabetes or CVD orcoronary artery disease and were not on any medication. Results The subjects smoke 32.3 ± 16.5 mean Pack Years. Theprevalence of the metabolic syndrome is 52.1%: 57.3% and 44.9% for males andfemales respectively. Analysing the smoking habit influence on the IDFcriteria for the metabolic syndrome diagnosis we found that all thevariables show an increasing trend from light to heavy smokers, except forHDL cholesterol. A statistical significant correlation among Pack Years andwaist circumference (R = 0.48, p < 0.0001),Systolic Blood Pressure (R = 0.18, p < 0.05),fasting plasma glucose (R = 0.19, p < 0.005) andHDL cholesterol (R = −0.26, p = 0.0005) hasbeen observed. Conclusions Currently smoking subjects are at high risk of developing the metabolicsyndrome. Therapeutic lifestyle changes, including smoking cessation are a desirablePublic health goal and should successfully be implemented in clinicalpractice at any age. © Cena et al.; licensee BioMed Central Ltd. 2013
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700
container_issue	1
title_short	Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers
url	https://dx.doi.org/10.1186/1758-5996-5-28
remote_bool	true
author2	Tesone, Antonella Niniano, Rosanna Cerveri, Isa Roggi, Carla Turconi, Giovanna
author2Str	Tesone, Antonella Niniano, Rosanna Cerveri, Isa Roggi, Carla Turconi, Giovanna
ppnlink	610606689
mediatype_str_mv	c
isOA_txt	true
hochschulschrift_bool	false
doi_str	10.1186/1758-5996-5-28
up_date	2024-07-03T14:53:24.542Z
_version_	1803570018578857984
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR030240395</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519143130.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2013 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1186/1758-5996-5-28</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR030240395</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)1758-5996-5-28-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Cena, Hellas</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Cena et al.; licensee BioMed Central Ltd. 2013</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background Smoking is an important cause of morbidity and mortality worldwide. It iswidely accepted as a major risk factor for metabolic and cardiovasculardisease. Smoking reduces insulin sensitivity or induces insulin resistanceand enhances cardiovascular risk factors such as elevated plasmatriglycerides, decreases high-density lipoprotein cholesterol and causeshyperglycemia. Several studies show that smoking is associated withmetabolic abnormalities and increases the risk of Metabolic Syndrome. Theaim of this study was to estimate the prevalence of the metabolic syndromein a group of light and heavy smokers, wishing to give up smoking. Methods In this cross-sectional study all the enrolled subjects voluntary joined thesmoking cessation program held by the Respiratory Pathophysiology Unit ofSan Matteo Hospital, Pavia, Northern Italy. All the subjects enrolled were former smokers from at least 10 years and hadno cancer or psychiatric disorders, nor history of diabetes or CVD orcoronary artery disease and were not on any medication. Results The subjects smoke 32.3 ± 16.5 mean Pack Years. Theprevalence of the metabolic syndrome is 52.1%: 57.3% and 44.9% for males andfemales respectively. Analysing the smoking habit influence on the IDFcriteria for the metabolic syndrome diagnosis we found that all thevariables show an increasing trend from light to heavy smokers, except forHDL cholesterol. A statistical significant correlation among Pack Years andwaist circumference (R = 0.48, p < 0.0001),Systolic Blood Pressure (R = 0.18, p < 0.05),fasting plasma glucose (R = 0.19, p < 0.005) andHDL cholesterol (R = −0.26, p = 0.0005) hasbeen observed. Conclusions Currently smoking subjects are at high risk of developing the metabolicsyndrome. Therapeutic lifestyle changes, including smoking cessation are a desirablePublic health goal and should successfully be implemented in clinicalpractice at any age.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Metabolic syndrome</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Smoking habit</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Insulin resistance</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Overweight</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Waist circumference</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tesone, Antonella</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Niniano, Rosanna</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cerveri, Isa</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Roggi, Carla</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Turconi, Giovanna</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Diabetology & metabolic syndrome</subfield><subfield code="d">London : BioMed Central, 2009</subfield><subfield code="g">5(2013), 1 vom: 30. Mai</subfield><subfield code="w">(DE-627)610606689</subfield><subfield code="w">(DE-600)2518786-7</subfield><subfield code="x">1758-5996</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:5</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:1</subfield><subfield code="g">day:30</subfield><subfield code="g">month:05</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1186/1758-5996-5-28</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">5</subfield><subfield code="j">2013</subfield><subfield code="e">1</subfield><subfield code="b">30</subfield><subfield code="c">05</subfield></datafield></record></collection>
score	7.399906

Nicht das Richtige dabei?

Schreiben Sie uns!

Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?